A Look At Austin’s First Pro Stadium

Spread across 1.3 million sf in Austin, Texas the new East Austin District will provide the fast-growing city with its first pro-sports stadium and large-scale music arena.

The 40,000-seat outdoor bowl is designed for large-scale soccer and rugby matches, music festivals, and other major events. The 15,000-seat multi-purpose arena is connected to the stadium and will serve as the home for Rodeo Austin, musical acts, basketball, and hockey.

The stadium and arena are joined by 190,000-sf of premium facilities and support functions. The separate buildings are unified by all-wooden interiors. Eight courtyards act as outdoor living rooms that connect the entire district. Visitors can gather in the public parks and plazas for communal gatherings, food truck scenes, recreation, and concerts. At the edge of the district are buildings for retail, shopping, dining, and hospitality. Youth education and enrichment are promoted via 28,000-sf of youth facilities.

Read the full article here

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More